Evidence map›Paper›PMID 37606845›Full record

ArticleJournal of nephrology2023

Hydroxychloroquine reduces proteinuria in Chinese patients with IgA vasculitis nephritis.

Chen Tang, Feng-Lei Si, Ji-Cheng Lv, Su-Fang Shi, Xu-Jie Zhou, Li-Jun Liu, Hong Zhang

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Chen TangRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Feng-Lei SiRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Ji-Cheng LvRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Su-Fang ShiRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Xu-Jie ZhouRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Li-Jun LiuRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China. lijun.liu@aliyun.com.ORCID http://orcid.org/0000-0003-2803-6956
Hong ZhangRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Ministry of Education of the People's Republic of China · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

CAMS Innovation Fund for Medical Sciences 2019-I2M-5-046The General Program (Key Program, Major Research Plan) of National Natural Science Foundation of China 82070731
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HydroxychloroquineIgA vasculitis nephritisProteinuriaRenin–angiotensin–aldosterone system inhibitors

Identifiers

PMID37606845
OpenAlexW4386046070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.